Stay updated on Nivolumab +/- Ipilimumab in NECs Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab in NECs Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA minor platform patch updates the version from v3.6.4 to v3.6.5, indicating an incremental release that does not appear to change the study details or content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, representing an internal update to the page version rather than changes to the study details.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3, signaling a maintenance or content update to the study page without altering its substantive details.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, representing a minor update to the page's versioning. This update does not imply a major change to the content or functionality.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now indicates that enrollment is closed for the study, and it adds new guidance sections to help users understand and join studies, while updating the Intervention/Treatment header formatting and revision version.SummaryDifference0.4%

- Check80 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a recent maintenance update to the site. The study details and displayed information remain the same.SummaryDifference0.1%

Stay in the know with updates to Nivolumab +/- Ipilimumab in NECs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.